HIV/Aids

25 July 2007

Treat HIV babies early

Infants born with HIV-infection have a greater chance of survival if they receive early treatment, according to a new report.

0
Infants born with HIV-infection have a greater chance of survival if they receive early treatment - before they show signs of a weakened immune system or HIV-related illness, according to a report presented Tuesday at the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment & Prevention.

A study of infants in Cape Town and Soweto, which began in 2005, found that 96 percent of infants given immediate drug treatment were still alive two years later, compared to only 84 percent of children given later treatment.

The study, by the US National Institute of Allergy and Infectious Disease (NIAID), was so successful that it was cut short by four years so that all children could receive treatment.

2.3 million kids infected
An estimated 2.3 million children are currently infected with HIV, with around 600 000 new HIV infections in children each year. Without treatment, half of all babies infected with HIV die before their second birthday.

"Children with HIV infection frequently show rapid disease progression within the first year of life due to their developing immune systems and susceptibility to other serious infections," said Dr Elias Zerhouni, director of the US National Institute of Health, during the study presentation.

"This is the first randomised clinical trial that shows that infants treated before three months of age will do better than infants who have their treatment delayed," Zerhouni said in a statement.

The study of 337 babies, between six and 12 weeks old, was initially aimed at examining whether early antiretroviral drug therapy over a limited period would delay HIV progression.

Doctors had hoped that early treatment would allow a child's immune system to develop and possibly allow the child to stop treatment for a period of time and avoid continuous therapy.

Study cut short
But a preliminary data review in 2007 found such a significant difference in survival rates that the study was cut short and the results forwarded to the World Health Organization.

"The results of this trial could have significant public health implications worldwide because these findings will cause experts to consider changes in standards of care in many parts of the world," said NIAID director Dr Anthony Fauci.

The current standard of HIV care in many parts of the world is to treat infants with antiretroviral therapy, but only after they show signs of illness or a weakened immune system.

The silent victims
Medecins Sans Frontieres (MSF) said children were the "silent victims" of the global Aids epidemic. Nine out of 10 children are HIV infected through mother-to-child transmission during pregnancy, childbirth or breastfeeding (known as "vertical transmission").

About 87 percent of children with HIV live in sub-Saharan Africa, with the vast majority beyond health services. Of the 540 000 children newly infected in 2006, the vast majority – 470 000 - live in Africa and only 700 in Europe or North America, said MSF.

MSF said vertical transmission of HIV is almost wiped out in wealthy countries by treating infected pregnant mothers and their infants with antiretroviral drugs within a few hours of birth.

Much worse in poor nations
The vertical transmission rate in wealthy nations was below 1 percent, compared with rates as high as 25 to 45 percent in poorer nations in Africa, said MSF.

The United Nations says close to 40 million people are infected with the Aids virus and that treatment had dramatically expanded from 240 000 people in 2001 to 1.3 million by 2005.

In June, world powers at the Group of Eight (G8) summit in Germany set a target of providing Aids drugs over the next few years to approximately 5 million people. – (ReutersHealth)

Read more:
HIV/Aids Centre

July 2007

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

HIV/Aids expert

Dr Sindisiwe van Zyl qualified at the University of Pretoria before working for an HIV/AIDS NPO in Soweto for many years. She was named one of the Mail & Guardian's Top 200 Young South Africans in 2012.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules